compounded glp-1 Noom offers cut-price drug for obesity Compounded GLP-1 - Semaglutide &
Description
This drug, a GLP-1 receptor agonist, leverages the effects of the naturally occurring satiety hormone glucagon-like peptide-1 (GLP-1)

A.AxsonS

For instance, should individuals with social obesity (overweight due to modern lifestyle but not yet diseased) use these drugs electively to lose weight

For instance, angiotensin converting enzyme inhibitors (ACEI), now a cornerstone for hypertension treatment, initially led to severe hypotension in dehydrated patients due to a lack of understanding of their potent effects

1 Factors that will affect the choice of the second agent include patient preference, cost, potential adverse effects, impact on weight, efficacy, and risk of hypoglycemia
Novo Nordisk is testing a weight loss pill of its own, amycretin
